LLS will select ten small molecule candidates deemed to have the best chance of quickly advancing to clinical trials from its portfolio of grant-funded academic research projects, and Forma will use its computational solvent mapping technology to ready the molecules for the clinic.
The plant is designed to accommodate Genentech's needs and those of its partner-turned-acquirer, Roche. The facility's packaging lines are now being validated, which is required for Genentech to begin making and shipping drugs.
The study suggests it is "unlikely" that patents protecting biomedical inventions "will ever be licensed" if they have remained unlicensed for more than eight years since their priority patent application was filed.
In Science this week: analysis of ancient Caribbean islanders' genomes suggests at least three waves of migration into the region, DNA barcoding of microbial spores, and more.
